Healthcare
3 evidence matches
Impact 100% Confidence 90%
Health
Sustaining Excellence in Medicaid Act of 2019 Became Public Law No: 116-39. Health
Sustaining Excellence in Medicaid Act of 2019 Became Public Law No: 116-39. Health
HR 3253 - 116Sustaining Excellence in Medicaid Act of 2019
Became Public Law No: 116-39.
Bill Text Stats
Bill text analysis is not available for this record yet.
Affected Sectors
How to read this
Sectors are deterministic matches from official Congress.gov data and cached bill text. They are source-derived signals, not conclusions about intent or economic effect.
Evidence matches count official fields, normalized subjects, cached text snippets, or extracted entities that matched the sector rules.
Impact is a bill-level rollup used for sorting and filtering. It is not an economic impact estimate.
Confidence is the strongest individual match score behind that sector.
Evidence snippets show why a sector matched and can repeat when Congress.gov repeats the same phrase across official fields.
CBO Cost Estimates
Official Congressional Budget Office cost estimate links associated with this bill through Congress.gov records.
How to read this
CBO estimates are official source documents with their own assumptions, scope, and publication dates. They can score a bill, a version of a bill, or a broader legislative package.
LawLinter stores the source link from Congress.gov and does not replace the CBO document. Use these cards as pointers for source review, not as independent fiscal advice.
CBO context shows source-attributed Congressional Budget Office cost estimates linked from official Congress.gov bill records. It is research context only; read the official CBO source document for assumptions, scope, and dates.
Campaign Finance Context
Related FEC/OpenFEC campaign-finance records for lawmakers and candidates tied to this bill through source-attributed legislative relationships. These are not donations to the bill itself.
How to read this
Amounts shown here are campaign-finance totals for sponsor or cosponsor-linked candidates and their committees in the displayed FEC cycle.
They are not donations to this bill, spending on this bill, or proof that money influenced or caused sponsorship, cosponsorship, votes, or legislative outcomes.
If multiple linked lawmakers have FEC records, this section can show multiple candidate cards and separate sponsor/cosponsor rollups.
Campaign-finance context uses source-attributed FEC/OpenFEC records that are related or relevant to the displayed bill, lawmaker, candidate, committee, or legislative relationship through deterministic links. It is research context only, not proof of influence, causation, endorsement, or that money caused a sponsorship, vote, or legislative outcome.
No FEC/OpenFEC campaign-finance context is currently linked for this bill.
Lobbying Context
Related LDA.gov filings where public lobbying activity descriptions reference this bill. These records are source-attributed research context, not evidence of influence or causation.
How to read this
LDA filings are public lobbying disclosure records. LawLinter links them here only when the filing activity text contains an exact-looking reference to this bill.
A filing can mention many issues, clients, agencies, or bills. A match should be treated as a pointer for review, not as a conclusion about why legislation changed or how any lawmaker acted.
Lobbying context uses source-attributed LDA.gov records that appear related to this bill through bill references in public lobbying activity descriptions. It is research context only, not proof of influence, causation, endorsement, lobbying effectiveness, or legislative intent.
No LDA.gov lobbying disclosure context is currently linked for this bill.
Summary
49 Public Law May 4, 2020
Sustaining Excellence in Medicaid Act of 2019 This bill extends several health care programs and requirements and revises certain Medicare drug payment methodologies. (Sec. 2) The bill temporarily extends the Medicaid demonstration program for certified community behavioral health clinics. (Sec. 3) The bill also temporarily extends the applicability of Medicaid eligibility criteria that protect against spousal impoverishment for recipients of home- and community-based services. (Sec. 4) The bill increases appropriations for FY2019 for the Money Follows the Person Rebalancing Demonstration Program. (Under this program, the Centers for Medicare & Medicaid Services (CMS) may award grants to state Medicaid programs to assist states in increasing the use of home and community care for long-term care and decreasing the use of institutional care.) (Sec. 5) Additionally, the bill extends the Family-to-Family Health Information Centers Program, which is administered by the Health Resources and Services Administration. The program awards grants to family-run organizations to support the provision of information and peer support to families of children with special health care needs. (Sec. 6) Finally, the bill provides statutory authority for a Medicare payment methodology that applies an add-on payment of up to 3% for new drugs or biologics (furnished on or after January 1, 2019) when the average sales price is unavailable and payment is instead based on the wholesale acquisition cost (WAC). (Effective January 1, 2019, the CMS reduced the WAC add-on payment in such situations from 6% to 3%.)
59 House agreed to Senate amendment May 4, 2020
Sustaining Excellence in Medicaid Act of 2019 This bill extends several health care programs and requirements and revises certain Medicare drug payment methodologies. (Sec. 2) The bill temporarily extends the Medicaid demonstration program for certified community behavioral health clinics. (Sec. 3) The bill also temporarily extends the applicability of Medicaid eligibility criteria that protect against spousal impoverishment for recipients of home- and community-based services. (Sec. 4) The bill increases appropriations for FY2019 for the Money Follows the Person Rebalancing Demonstration Program. (Under this program, the Centers for Medicare & Medicaid Services (CMS) may award grants to state Medicaid programs to assist states in increasing the use of home and community care for long-term care and decreasing the use of institutional care.) (Sec. 5) Additionally, the bill extends the Family-to-Family Health Information Centers Program, which is administered by the Health Resources and Services Administration. The program awards grants to family-run organizations to support the provision of information and peer support to families of children with special health care needs. (Sec. 6) Finally, the bill provides statutory authority for a Medicare payment methodology that applies an add-on payment of up to 3% for new drugs or biologics (furnished on or after January 1, 2019) when the average sales price is unavailable and payment is instead based on the wholesale acquisition cost (WAC). (Effective January 1, 2019, the CMS reduced the WAC add-on payment in such situations from 6% to 3%.)
55 Passed Senate May 1, 2020
Sustaining Excellence in Medicaid Act of 2019 This bill extends several health care programs and requirements and revises certain Medicare drug payment methodologies. (Sec. 2) The bill temporarily extends the Medicaid demonstration program for certified community behavioral health clinics. (Sec. 3) The bill also temporarily extends the applicability of Medicaid eligibility criteria that protect against spousal impoverishment for recipients of home- and community-based services. (Sec. 4) The bill increases appropriations for FY2019 for the Money Follows the Person Rebalancing Demonstration Program. (Under this program, the Centers for Medicare & Medicaid Services (CMS) may award grants to state Medicaid programs to assist states in increasing the use of home and community care for long-term care and decreasing the use of institutional care.) (Sec. 5) Additionally, the bill extends the Family-to-Family Health Information Centers Program, which is administered by the Health Resources and Services Administration. The program awards grants to family-run organizations to support the provision of information and peer support to families of children with special health care needs. (Sec. 6) Finally, the bill provides statutory authority for a Medicare payment methodology that applies an add-on payment of up to 3% for new drugs or biologics (furnished on or after January 1, 2019) when the average sales price is unavailable and payment is instead based on the wholesale acquisition cost (WAC). (Effective January 1, 2019, the CMS reduced the WAC add-on payment in such situations from 6% to 3%.)
53 Passed House Dec 12, 2019
Empowering Beneficiaries, Ensuring Access, and Strengthening Accountability Act of 2019 This bill alters several Medicaid programs and funding mechanisms. Specifically, the bill makes appropriations through FY2024 for, and otherwise revises, the Money Follows the Person Rebalancing Demonstration Program; allows state Medicaid fraud control units to review complaints regarding patients who are in noninstitutional or other settings; temporarily extends the applicability of Medicaid eligibility criteria that protect against spousal impoverishment for recipients of home and community-based services; temporarily extends the Medicaid demonstration program for certified community behavioral health clinics; repeals the requirement, under the Medicaid Drug Rebate Program, that drug manufacturers include the prices of certain authorized generic drugs when determining the average manufacturer price (AMP) of brand-name drugs (also known as a "blended AMP"), and excludes manufacturers from the definition of "wholesalers" for purposes of rebate calculations; and increases funding available to the Medicaid Improvement Fund beginning in FY2021.
00 Introduced in House Dec 11, 2019
Empowering Beneficiaries, Ensuring Access, and Strengthening Accountability Act of 2019 This bill alters several Medicaid programs and funding mechanisms. Specifically, the bill makes appropriations through FY2024 for, and otherwise revises, the Money Follows the Person Rebalancing Demonstration Program; allows state Medicaid fraud control units to review complaints regarding patients who are in noninstitutional or other settings; temporarily extends the applicability of Medicaid eligibility criteria that protect against spousal impoverishment for recipients of home and community-based services; temporarily extends the Medicaid demonstration program for certified community behavioral health clinics; repeals the requirement, under the Medicaid Drug Rebate Program, that drug manufacturers include the prices of certain authorized generic drugs when determining the average manufacturer price (AMP) of brand-name drugs (also known as a "blended AMP"), and excludes manufacturers from the definition of "wholesalers" for purposes of rebate calculations; and increases funding available to the Medicaid Improvement Fund beginning in FY2021.
Sponsors
Website
N/A
Phone
N/A
Office
N/A
Timeline
Aug 6, 2019
Signed by President.
Aug 6, 2019
Signed by President.
Aug 6, 2019
Became Public Law No: 116-39.
Aug 6, 2019
Became Public Law No: 116-39.
Aug 1, 2019
Presented to President.
Aug 1, 2019
Presented to President.
Jul 30, 2019
Ms. Norton asked unanimous consent to take from the Speaker's Table and agree to the Senate amendment. (consideration: CR H7477-7478)
Jul 30, 2019
Resolving differences -- House actions: On motion that the House agree to the Senate amendment Agreed to without objection.(text: CR H7477-7478)
Jul 30, 2019
On motion that the House agree to the Senate amendment Agreed to without objection. (text: CR H7477-7478)
Jul 30, 2019
Motion to reconsider laid on the table Agreed to without objection.
Jul 25, 2019
Measure laid before Senate by unanimous consent. (consideration: CR S5114)
Jul 25, 2019
Passed/agreed to in Senate: Passed Senate with an amendment by Voice Vote.
Jul 25, 2019
Passed Senate with an amendment by Voice Vote.
Jul 25, 2019
Message on Senate action sent to the House.
Jun 19, 2019
Received in the Senate, read twice.
Jun 18, 2019
Mrs. Dingell moved to suspend the rules and pass the bill, as amended.
Jun 18, 2019
Considered under suspension of the rules. (consideration: CR H4706-4710)
Jun 18, 2019
DEBATE - The House proceeded with forty minutes of debate on H.R. 3253.
Jun 18, 2019
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Jun 18, 2019
Considered as unfinished business. (consideration: CR H4751)
Jun 18, 2019
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 371 - 46 (Roll no. 333).(text: CR H4706-4707)
Jun 18, 2019
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 371 - 46 (Roll no. 333). (text: CR H4706-4707)
Jun 18, 2019
Motion to reconsider laid on the table Agreed to without objection.
Jun 13, 2019
Introduced in House
Jun 13, 2019
Introduced in House
Jun 13, 2019
Referred to the House Committee on Energy and Commerce.
House Votes
No House roll call votes have been linked to this bill yet.
Amendments
No amendment records are currently available for this bill.
Compiled bill record. Bill pages combine Congress.gov source payloads, normalized relationships, cached text analysis, vote links, and deterministic sector/signal extraction. This is not an official government record or legal advice; use the official source link when accuracy matters.